Hispanic Americans Have Lower Cancer Risk
Hispanic (Latino) Americans are less likely than non-Hispanic whites to develop and die from all cancers combined as well as the four most common cancers (female breast cancer, prostate, colorectal, and lung) according to a new report.
However, Hispanics have higher rates of several cancers related to infections (stomach, liver, and cervix) and are more likely to have cancer detected at a later stage.
The findings come from the latest edition of Cancer Facts & Figures for Hispanics/Latinos. Hispanic Americans comprise the largest, fastest-growing, and youngest minority in the United States. An estimated 98,900 new cancer cases will be diagnosed in Hispanic/Latinos in 2009. Prostate cancer is the most commonly diagnosed cancer in men, while breast cancer is the most common cancer among women. Colorectal cancer is the second-most common cancer in both men and women.
Cancer is the second leading cause of death in the United States, exceeded only by heart disease according to the American Association for Critical Illness Insurance. More than 1.44 million Americans had a diagnosis of cancer in 2008 and some 565,000 died. According to the National Institutes of Health, cancer cost the United States an estimated $228 billion in medical costs in 2008.
An estimated 18,800 Hispanics are expected to die from cancer in 2009; the top two causes of cancer death among men are lung and colorectal cancer, while breast and lung cancer are the top two in women.
Between 1997 and 2006, cancer incidence rates decreased among Hispanics by 1.3% per year in men and 0.6% per year in women, compared to decreases of 0.8% per year and 0.4% per year in non-Hispanic white men and women, respectively.
During the same time period, cancer death rates among Hispanics decreased by 2.2% per year in men and 1.2% per year in women, compared to decreases in non-Hispanic whites of 1.5% per year in men and 0.9% per year in women.
The report also finds that compared to non-Hispanic whites, Hispanic/Latino Americans have a later stage of diagnosis for many cancers, including breast and melanoma and have generally similar 5-year survival, except for melanoma, for which survival rates are lower in Hispanic compared to non-Hispanic white men (79% versus 87%) and women (88% versus 92%).
Written by Jesse Slome from the American Association for Critical Illness Insurance